Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 15/20 | 0.58 |
| ▸ | PPARA | Q07869 | 15/20 | 0.58 |
| ▸ | PPARD | Q03181 | 8/20 | 0.58 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | CPA1 | P15085 | 1/20 | 0.45 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7108323 | 0.85 | SLC7A5 (0.51) | PPARGPPARAPPARDSRR | |
| SCHEMBL5607289 | 0.85 | SLC7A5 (0.51) | PPARGPPARAPPARDSRR | |
| SCHEMBL7108081 | 0.85 | SLC7A5 (0.51) | PPARGPPARAPPARDSRR | |
| SCHEMBL8023124 | 0.84 | SRR (0.62) | PPARGPPARASRR | |
| SCHEMBL24328238 | 0.84 | SRR (0.62) | PPARGPPARASRR | |
| SCHEMBL4335537 | 0.83 | KMT2A (0.58) | PPARGPPARAPPARD | |
| SCHEMBL24328239 | 0.83 | PPARG (0.59) | PPARGPPARAPPARDCPA1SRR | |
| SCHEMBL24328379 | 0.80 | PPARA (0.66) | PPARGPPARAPPARD | |
| SCHEMBL13819362 | 0.80 | MMP1 (0.55) | PPARGPPARAPPARD | |
| SCHEMBL4347157 | 0.80 | PPARA (0.61) | PPARGPPARAPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230399297-A1 | Novel Glutamine Analogs | JACOBIO PHARMACEUTICALS CO., LTD (CN) | 2023-12-14 | — | — | US | disclosed |
| US-20230399297-A1 | Novel Glutamine Analogs | JACOBIO PHARMACEUTICALS CO., LTD (CN) | 2023-12-14 | — | — | US | disclosed |
| WO-2022078416-A1 | NOVEL GLUTAMINE ANALOGS | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2022-04-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230399297-A1 | Novel Glutamine Analogs | GLUL, GATD3, GLS | PPARG 1211/4885PPARA 1857/4885PPARD 1270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.